Log in

Relevant bibliographies by topics / Hepatitis B virus and hepatitis C virus / Journal articles

To see the other types of publications on this topic, follow the link: Hepatitis B virus and hepatitis C virus.

Journal articles on the topic 'Hepatitis B virus and hepatitis C virus'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Hepatitis B virus and hepatitis C virus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

AYGEN, Bilgehan, Mustafa Kemal ÇELEN, İftihar KÖKSAL, et al. "The Prevalence and Epidemiological Characteristics of Hepatitis B Virus and Hepatitis C Virus Coinfection in Turkey." Turkiye Klinikleri Journal of Medical Sciences 33, no. 5 (2013): 1245–49. http://dx.doi.org/10.5336/medsci.2012-32319.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Anjum, Muhammad Usman, Muhammad Safdar Khan, Nazar Muhamamd Afridi, and Syed Humayun Shah. "HEPATITIS B AND C VIRUS INFECTIONS." Professional Medical Journal 22, no. 10 (2015): 1284–88. http://dx.doi.org/10.29309/tpmj/2015.22.10.981.

Full text

Abstract:

Patients with end stage renal disease require haemodialysis as a part of theirtreatment. The incidence of hepatitis B and C virus infection is quite high in patients undergoingmaintenance haemodialysis than in general population. This risk is specifically associatedwith use of blood and its products as well as repeated intravascular access in these patients.Objectives: To determine the seropositivity of hepatitis B and C virus infection in patientsreceiving haemodialysis. Design: Descriptive cross sectional study. Setting: NephrologyDepartment, Ayub Teaching Hospital, Abbottabad, Pakistan. Per

APA, Harvard, Vancouver, ISO, and other styles

3

Vijendra, Singh Rawat, Ranjan Neelima, Jain Isha, and Bharat Jain Savita. "Hepatitis B and Hepatitis C - Seroprevalence and Correlation with C-Reactive Protein." International Journal of Pharmaceutical and Clinical Research 15, no. 6 (2023): 2003–8. https://doi.org/10.5281/zenodo.12529982.

Full text

Abstract:

<strong>Background: </strong>Viral hepatitis caused by Hepatitis B(HBV) and Hepatitis C virus (HCV) is a major public health problem specially in developing countries like India. <strong>Materials and Methods: </strong>Three hundred blood samples were collected from patients having clinical sign and symptoms of hepatitis and apparently healthy pregnant females. Detection of hepatitis B surface antigen, antibodies against hepatitis C virus and C reactive protein (CRP) was done in these samples. <strong>Results:</strong> The seroprevalence of HBV and HCV in our study sam

APA, Harvard, Vancouver, ISO, and other styles

4

Soni, Dr Payal, Dr Dipa Kinariwala, Dr Neeta Khandelwal, Dr Mehul Patel, Dr P. K. Shah Dr. P. K. Shah, and Dr M. M. Vegad Dr. M. M. Vegad. "Co-Infection of Hepatitis C Virus and Hepatitis B Virus in Human Immuno Deficiency Virus Positive Population in Ahmedabad, Gujarat." International Journal of Scientific Research 2, no. 9 (2012): 17–18. http://dx.doi.org/10.15373/22778179/sep2013/158.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

GUPTA, NEHA, SIMA K. BHATT, and AMI M. SHAH. "Seroprevalence of Hepatitis-B Virus, Human Immunodeficiency Virus & Hepatitis-C Virus in Corneal Donors in Tertiary Care Centre, Ahmedabad." International Journal of Scientific Research 3, no. 2 (2012): 455–56. http://dx.doi.org/10.15373/22778179/feb2014/150.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bhamidimarri, Kalyan Ram, James Park, and Douglas Dieterich. "Management of Hepatitis B Virus Coinfection: HIV, Hepatitis C Virus, Hepatitis D Virus." Current Hepatitis Reports 10, no. 4 (2011): 262–68. http://dx.doi.org/10.1007/s11901-011-0115-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Caccamo, Gaia. "Hepatitis B virus and hepatitis C virus dual infection." World Journal of Gastroenterology 20, no. 40 (2014): 14559. http://dx.doi.org/10.3748/wjg.v20.i40.14559.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Shih, Yi-Fen, and Chun-Jen Liu. "Hepatitis C Virus and Hepatitis B Virus Co-Infection." Viruses 12, no. 7 (2020): 741. http://dx.doi.org/10.3390/v12070741.

Full text

Abstract:

Hepatitis C virus (HCV) and hepatitis B virus (HBV) co-infection can be encountered in either virus endemic countries. Co-infection can also be found in populations at risk of parenteral transmission. Previous studies demonstrated a high risk of liver disease progression in patients with HCV/HBV co-infection; thus, they should be treated aggressively. Previous evidence recommended therapy combining peginterferon (pegIFN) alfa and ribavirin for co-infected patients with positive HCV RNA. Recent trials further advise using direct-acting antivirals (DAAs) for the clearance of HCV in the co-infect

APA, Harvard, Vancouver, ISO, and other styles

9

Mosley, JW. "Coinfection with hepatitis C virus and hepatitis B virus." Biomedicine & Pharmacotherapy 49, no. 1 (1995): 47–48. http://dx.doi.org/10.1016/0753-3322(96)82584-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Korb, G. "Chronische Hepatitis-B-Virus- und Hepatitis-C-Virus-Infektion." Der Pathologe 22, no. 2 (2001): 124–31. http://dx.doi.org/10.1007/s002920000449.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Carreño*, Vicente, Javier Bartolomé, Inmaculada Castillo, and Juan Antonio Quiroga. "Occult hepatitis B virus and hepatitis C virus infections." Reviews in Medical Virology 18, no. 3 (2008): 139–57. http://dx.doi.org/10.1002/rmv.569.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Cramp, M. E., H. C. Grundy, R. M. Perinpanayagam, and D. E. Barnado. "Seroprevalence of Hepatitis B and C Virus in Two Institutions Caring for Mentally Handicapped Adults." Journal of the Royal Society of Medicine 89, no. 7 (1996): 401–2. http://dx.doi.org/10.1177/014107689608900712.

Full text

Abstract:

Hepatitis B virus infection is common in institutions caring for the mentally handicapped. Hepatitis B virus and hepatitis C virus share routes of transmission but the prevalence of hepatitis C virus infection in this population is unknown. We have tested 101 patients from two institutions in South-East England caring for adults with mental handicap for the presence of hepatitis C antibody, hepatitis B core antibody, and if necessary hepatitis B surface antigen. None tested positive for hepatitis C antibody, but 43 had hepatitis B core antibody of whom 14 were chronic carriers positive for hep

APA, Harvard, Vancouver, ISO, and other styles

13

Shamsa, Arshad Butt, Akram Ammara, Firdous Maryam, and Hussain Shafaat. "Analysis of Risk Factors of Hepatitis B and Hepatitis C in Pakistan." systematic reviews in pharmacy 12, no. 4 (2021): 224–26. https://doi.org/10.5281/zenodo.4876028.

Full text

Abstract:

ABSTRACT Introduction: Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are among the principal causes of severe liver disease, including hepatocellular carcinoma and cirrhosis-related end-stage liver disease. The World Health Organization (WHO) estimates that there are 350 million people with chronic HBV infection and 170 million people with chronic HCV infection worldwide. Aims and objectives: The basic aim of the study is to find the risk factors of hepatitis B and C among local population of Pakistan. Methodology of the study: This descriptive study was conducted at Holy Family Hospital

APA, Harvard, Vancouver, ISO, and other styles

14

Ghazi Turki, Salwa. "Social Problem among Hepatitis C and B Virus Patients." Journal of Communicable Diseases 57, no. 01 (2025): 144–50. https://doi.org/10.24321/0019.5138.202519.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Dar, Ghayas Ud Din, Muhammad Imran Qader, Shafique Ahmed Chudhary, Dania Aijaz, Shahid Imtiaz, and Tahir Naveed. "Frequency of HBsAg and Anti-HCV among Hemodialysis Patients in Three General Hospitals of Azad Kashmir." International Journal of Frontier Sciences 4, no. 1 (2020): 52–54. https://doi.org/10.5281/zenodo.3613537.

Full text

Abstract:

<strong>ABSTRACT</strong> <strong>Background</strong>: The impact of dialysis modality on the rates and types of infectious complications has not been well studied. The aim of the present investigation was to evaluate the rates of hepatitis C virus and hepatitis B virus infections in hemodialysis patients in three general hospitals of Azad Kashmir. In dialysis patient, if left unaddressed these may lead to very fatal consequences at the individual and national level. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections represent significant public health issues globally. These infect

APA, Harvard, Vancouver, ISO, and other styles

16

Calmet Schwartzmann, Fernando H., and Fernando H. Calmet Bruhn. "Hepatitis C." Diagnóstico 56, no. 1 (2018): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.119.

Full text

Abstract:

El virus de la hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis Ay B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis "no A, no B". No fue hasta 1989 que se aisló el VHC por primera vez y entre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mu

APA, Harvard, Vancouver, ISO, and other styles

17

Calmet Schwartzmamn, Fernando H., and Fernando H. Calmet Bruhn. "Hepatitis C." Diagnóstico 56, no. 1 (2020): 24–30. http://dx.doi.org/10.33734/diagnostico.v56i1.166.

Full text

Abstract:

El virus de hepatitis C (VHC) es un virus monocatenario ARN perteneciente al género Hepacivirus de la familia Flaviviridae. En la década de 1970, tras el descubrimiento de hepatitis A y B, se hizo claro que había casos de hepatitis post-transfusión que no podían ser explicados por estos virus, llevando a la descripción de hepatitis ''no A, no B''. No fue hasta 1989 que se aisló el VHC por primera vez y emtre 1990 y 1992 se desarrolló y refinó una prueba de anticuerpos anti-VHC que fue implementado en los bancos de sangre, llevando a una gran reducción de la transmisión de este virus a nivel mu

APA, Harvard, Vancouver, ISO, and other styles

18

Gastaminza Landart, Pablo. "FROM THE DICOVERY OF NON-A, NON-B HEPATITIS VIRUS TOWARDS HEPATITIS C VIRUS ELIMINATION." Anales de la Real Academia Nacional de Farmacia, no. 86(04) (2020): 291–98. http://dx.doi.org/10.53519/analesranf.2020.86.04.07.

Full text

Abstract:

In october 5 2020, the Nobel Assembly and the Nobel Committee for Physiology or Medicine, announced that three scientists Drs. Harvey Later, Michael Houghton and Charles Rice were the awarded with the Nobel prize in Medicine 2020 “for the discovery of the hepatitis C virus”. Hepatitis C virus (HCV) in one of several viruses capable of causing chronic liver inflammation and life-threatening pathologies like cirrhosis and hepatocellular carcinoma. Dr. Harvey Alter observations at the NIH Clinical Center prompted the postulate of a virus that was different from the hepatitis A and hepatitis B vir

APA, Harvard, Vancouver, ISO, and other styles

19

Mitre, Heloísa Pedrosa, and João Silva de Mendonça. "Co-infection with hepatitis B virus and hepatitis C virus." Brazilian Journal of Infectious Diseases 11 (October 2007): 33–35. http://dx.doi.org/10.1590/s1413-86702007000700011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Tovo, Pier-Angelo, Luisella Lazier, and Antonia Versace. "Hepatitis B virus and hepatitis C virus infections in children." Current Opinion in Infectious Diseases 18, no. 3 (2005): 261–66. http://dx.doi.org/10.1097/01.qco.0000168388.24142.2b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Fattovich, G., A. Tagger, L. Brollo, et al. "Hepatitis C Virus Infection in Chronic Hepatitis B Virus Carriers." Journal of Infectious Diseases 163, no. 2 (1991): 400–402. http://dx.doi.org/10.1093/infdis/163.2.400.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

De Vroey, Bénédicte, Christophe Moreno, Wim Laleman, et al. "Hepatitis B virus and hepatitis C virus infections in Belgium." European Journal of Gastroenterology & Hepatology 25, no. 5 (2013): 613–19. http://dx.doi.org/10.1097/meg.0b013e32835d83a2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Costa, J., J. M. Sánchez-Tapias, J. M. Barrerax, et al. "Influence of hepatitis C virus on hepatitis B virus infection." Journal of Hepatology 11 (January 1990): S18. http://dx.doi.org/10.1016/0168-8278(90)91405-l.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Rehermann, Barbara, and Michelina Nascimbeni. "Immunology of hepatitis B virus and hepatitis C virus infection." Nature Reviews Immunology 5, no. 3 (2005): 215–29. http://dx.doi.org/10.1038/nri1573.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Liu, Chun-Jen, Pei-Jer Chen, and Ding-Shinn Chen. "Dual chronic hepatitis B virus and hepatitis C virus infection." Hepatology International 3, no. 4 (2009): 517–25. http://dx.doi.org/10.1007/s12072-009-9147-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ohkawa, Kazuyoshi, Norio Hayashi, Nobukazu Yuki, et al. "Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients." Journal of Hepatology 21, no. 4 (1994): 509–14. http://dx.doi.org/10.1016/s0168-8278(94)80094-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Gedefie, Alemu, Abdurahaman Seid, Genet Molla Fenta, Mihret Tilahun, Agumas Shibabaw, and Abdurrahman Ali. "Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross-sectional study." SAGE Open Medicine 11 (January 2023): 205031212311666. http://dx.doi.org/10.1177/20503121231166642.

Full text

Abstract:

Objective: Viral hepatitis, particularly hepatitis B virus and hepatitis C virus, is the leading cause of global liver-related morbidity and mortality. Concomitant infections of hepatitis B virus, hepatitis C virus, and tuberculosis are risks of hepatotoxicity and death due to antituberculosis therapy. Hepatitis and human immunodeficiency virus coinfection poses challenges in treating hepatotoxic patients and leads to mortality during antituberculosis treatment. Thus, this study aimed to determine the prevalence of hepatitis B virus and hepatitis C virus infections, and associated factors amon

APA, Harvard, Vancouver, ISO, and other styles

28

Meng, Xiang Wei, Masafumi Komatsu, Shigetoshi Ohshima, et al. "GB Virus C Infection: Clinical Significance." Canadian Journal of Gastroenterology 13, no. 10 (1999): 814–18. http://dx.doi.org/10.1155/1999/430279.

Full text

Abstract:

GB virus C (GBV-C) RNA positivity rates were examined in serum specimens from 231 patients with liver disease (23 patients with hepatitis B, 175 patients with hepatitis C, five patients with hepatitis B virus plus hepatitis C virus coinfection, and 28 patients with non-A, non-B, non-C hepatitis) to clarify the clinical significance of this virus. GBV-C RNA was detected in none of 12 patients with fulminant hepatitis, one of two patients with acute hepatitis positive for hepatitis B surface antigen and one of four patients with acute non-A, non-B, non-C hepatitis. Pathogenetic involvement of GB

APA, Harvard, Vancouver, ISO, and other styles

29

Nguyen, Tuyet A. T., and Richard K. Sterling. "Viral hepatitis B coinfection with human immunodeficiency virus, hepatitis D virus, or hepatitis C virus." Clinical Liver Disease 2, no. 1 (2013): 45–48. http://dx.doi.org/10.1002/cld.146.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Liaw, Yun-Fan. "Concurrent hepatitis B and C virus infection: Is hepatitis C virus stronger?" Journal of Gastroenterology and Hepatology 16, no. 6 (2001): 597–98. http://dx.doi.org/10.1046/j.1440-1746.2001.02523.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Renou, Christophe, Jean-François Cadranel, Alexandre Pariente, et al. "Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers." European Journal of Gastroenterology & Hepatology 20, no. 12 (2008): 1235–37. http://dx.doi.org/10.1097/meg.0b013e328305ba2a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Al-Khazraji, Khalid A. "Comparison study between the treatment of Hepatitis C virus with (peg-interferon, ribavirin, silymarin) and (peg-interferon, ribavirin) in Baghdad teaching hospital." Journal of the Faculty of Medicine Baghdad 59, no. 1 (2017): 14–18. http://dx.doi.org/10.32007/jfacmedbagdad.591150.

Full text

Abstract:

Background: Infection with Hepatitis C virus (HCV) is a major cause of chronic liver disease, WHO estimated that about 170 million people are infected with Hepatitic C virus, Silymarin (Legalon) have been recently shown to be effective in treatment of Hepatitic C virus infection.Objectives: The effectiveness of Legalon (Silymarin) on viral load in patients with Hepatitic C virus infection.Patients and methods: A prospective case – control study included 400 patients with Hepatitis C virus infection. 200 patients (group A) were treated with (peg-interferon, ribavirin, silymarin) the other 200 p

APA, Harvard, Vancouver, ISO, and other styles

33

Shukla, Nilesh B., and Michael A. Poles. "Hepatitis B virus infection: co-infection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus." Clinics in Liver Disease 8, no. 2 (2004): 445–60. http://dx.doi.org/10.1016/j.cld.2004.02.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Ullah, Qudrat, Usman Ali Rehman, Asif Hanif, and Sami Ullah Bhatti. "Frequency of Parenteral Exposure and Seroprevalence of HBV, HCV and HIV among Operating Room Personnel." International Journal of Frontier Sciences 2, no. 2 (2018): 3–10. https://doi.org/10.5281/zenodo.2545981.

Full text

Abstract:

Abstract Background: There are many experiences in the operation theatre professionals to get Hepatitis B virus, Hepatitis C virus and Human immunodeficiency virus during their profession in operating room due to accidental needle pricks or through cut by any sharp. The objective of this study is to find out the Frequency of parenteral exposure and seroprevalence of HBV, HCV and HIV among operating room personnel. Methodology: Frequency of parenteral exposure and seroprevalence of HBV, HCV and HIV among operating room personnel was found using ICT method. Results: All 108 (100 %) operating roo

APA, Harvard, Vancouver, ISO, and other styles

35

Austin, Publishing Group. "Tackling the Burden of Viral Hepatitis in India: A Call for Collaborative Efforts." Journal of Hepatitis Research 8, no. 1 (2023): 1049. https://doi.org/10.26420/jhepatres.2023.1049.

Full text

Abstract:

Viral hepatitis is defined as a widespread infectious disease involving the inflammation of liver caused by hepatitis virus A, B, C, D and E. The majority of deaths linked to viral hepatitis are caused by HBV, HCV, and HDV, which are transmitted parenterally and induce chronic hepatitis with distant sequelae like liver cirrhosis and hepatocellular cancer [1]. According to WHO latest estimates, viral hepatitis is now acknowledged as a serious public health problem in India with over 40 million people chronically infected with HBV and six to twelve million people with HCV. In a study dated in 20

APA, Harvard, Vancouver, ISO, and other styles

36

Braga, Wornei Silva Miranda, Márcia da Costa Castilho, Isabelle Cristina Vale dos Santos, Marco Antônio Sabóia Moura, and Aluisio Cotrim Segurado. "Low prevalence of hepatitis B virus, hepatitis D virus and hepatitis C virus among patients with human immunodeficiency virus or acquired immunodeficiency syndrome in the Brazilian Amazon basin." Revista da Sociedade Brasileira de Medicina Tropical 39, no. 6 (2006): 519–22. http://dx.doi.org/10.1590/s0037-86822006000600001.

Full text

Abstract:

Comorbidities in human immunodeficiency virus infection are of great interest due to their association with unfavorable outcomes and failure of antiretroviral therapy. This study evaluated the prevalence of coinfection by human immunodeficiency virus and viral hepatitis in an endemic area for hepatitis B in the Western Amazon basin. Serological markers for hepatitis B virus, hepatitis C virus and hepatitis D virus were tested in a consecutive sample of all patients referred for treatment of human immunodeficiency virus or acquired immunodeficiency syndrome. The variables sex, age, origin and e

APA, Harvard, Vancouver, ISO, and other styles

37

Babar, Javaid, Amir Gillani Syed, Ali Siddiqui Mustafa, et al. "Correlation of Sonographic Appearance of Chronic Liver Disease with Serological Findings of Hepatitis B and C in Multan City." Journal of Health and Medical Sciences 2, no. 2 (2019): 202–13. https://doi.org/10.31014/aior.1994.02.02.38.

Full text

Abstract:

Liver cirrhosis is the irrecoverable disease of the liver, finally it causes necrosis of liver cells, as a result, change normal cells into an abnormal knot as well as structural abnormalities occur. It caused by many of reason, but here we discussed only by the hepatitis b virus and hepatitis b virus. The hazard of liver cirrhosis increased day by day. Recently liver cirrhosis prevalence of Pakistan was 13.5%. Sonography can easily diagnose the liver cirrhosis caused by hepatitis b and c virus. Objective: The object of this study to examine the analyses of ultra-sonographic diagnosis of liver

APA, Harvard, Vancouver, ISO, and other styles

38

Saraceni, Corey, and John Birk. "A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis." Journal of Clinical and Translational Hepatology 000, no. 000 (2021): 000. http://dx.doi.org/10.14218/jcth.2020.00095.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Coppola, Nicola. "Hepatitis B virus and hepatitis C virus infection in healthcare workers." World Journal of Hepatology 8, no. 5 (2016): 273. http://dx.doi.org/10.4254/wjh.v8.i5.273.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Chang, Chun-Hung, Chieh-Yu Liu, Shaw-Ji Chen, and Hsin-Chi Tsai. "Hepatitis C virus and hepatitis B virus in patients with schizophrenia." Medicine 100, no. 22 (2021): e26218. http://dx.doi.org/10.1097/md.0000000000026218.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Kallman, J. B., S. Tran, A. Arsalla, et al. "Vietnamese community screening for hepatitis B virus and hepatitis C virus." Journal of Viral Hepatitis 18, no. 1 (2010): 70–76. http://dx.doi.org/10.1111/j.1365-2893.2010.01278.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Kaewdech, Apichat, Phunchai Charatcharoenwitthaya, and Teerha Piratvisuth. "Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination." Viruses 17, no. 1 (2024): 34. https://doi.org/10.3390/v17010034.

Full text

Abstract:

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain significant public health challenges in Asia, affecting millions and contributing to substantial morbidity and mortality. The prevalence of these infections varies across the region, with factors such as vaccination coverage, healthcare infrastructure, and sociocultural barriers influencing the epidemiology of both viruses. The persistent burden of chronic HBV, particularly in older populations, and the evolving HCV genotype landscape highlight the need for targeted, region-specific strategies. Universal screening programs h

APA, Harvard, Vancouver, ISO, and other styles

43

Elsheikh, Rasha M., Ahmed A. Daak, Mohamed A. Elsheikh, Mubarak S. Karsany, and Ishag Adam. "Hepatitis B virus and hepatitis C virus in pregnant Sudanese women." Virology Journal 4, no. 1 (2007): 104. http://dx.doi.org/10.1186/1743-422x-4-104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Hwang, Jessica P., and Harrys A. Torres. "Hepatitis B virus and hepatitis C virus infection in immunocompromised patients." Current Opinion in Infectious Diseases 31, no. 6 (2018): 535–41. http://dx.doi.org/10.1097/qco.0000000000000500.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Hung, Chao-Hung, Chuan-Mo Lee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, and Tsung-Hui Hu. "Hepatic steatosis with hepatitis B virus/hepatitis C virus dual infection." Hepatology 52, no. 4 (2010): 1521–22. http://dx.doi.org/10.1002/hep.23740.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Chlabicz, S., and A. Grzeszczuk. "Hepatitis B Virus Vaccine for Patients with Hepatitis C Virus Infection." Infection 28, no. 6 (2000): 341–45. http://dx.doi.org/10.1007/s150100070002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Shen, Yu-Chuan, Hui-Ching Hsu, Tzu-Min Lin, et al. "H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection." Journal of Clinical Oncology 40, no. 11 (2022): 1206–19. http://dx.doi.org/10.1200/jco.21.01802.

Full text

Abstract:

PURPOSE H1-antihistamines (AHs) may exert protective effects against cancer. This study investigated the association of AH use with the risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV), hepatitis C virus (HCV), or dual HBV-HCV virus infection. MATERIALS AND METHODS Patients with HBV, HCV, or dual HBV-HCV infection were enrolled from Taiwan's National Health Insurance Research Database and examined for the period from January 1, 2006, to December 31, 2015. We used the Kaplan-Meier method and Cox proportional hazards regression to evaluate the association between A

APA, Harvard, Vancouver, ISO, and other styles

48

Ho, Tinh Huu. "Prevalence of Hepatitis B Virus and Hepatitis C Virus Infections among Beauticians in Quy Nhon City, Binh Dinh Province, Vietnam." Journal of Integrated Community Health 07, no. 01 (2018): 31–41. http://dx.doi.org/10.24321/2319.9113.201806.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Singh, Lovepreet, Swati Mittal, Amandeep Kaur, Surinder Singh, Ravi K. Tiwary, and Harjinder Singh. "Hepatitis B virus and hepatitis C virus co-infection among outdoor patients and indoor patients of tertiary care institute, Bathinda, Punjab, India." International Journal of Research in Medical Sciences 8, no. 9 (2020): 3252. http://dx.doi.org/10.18203/2320-6012.ijrms20203672.

Full text

Abstract:

Background: Hepatitis virus infections have many serious consequences like chronic hepatitis, fulminant hepatitis, liver cirrhosis, hepatocellular carcinoma and liver cancer. Serological test is thus necessary to identify hepatitis virus in the body. An observational study was conducted with an objective to detect hepatitis B surface antigen (HBsAg) and anti-hepatitis C virus (HCV) antibodies by rapid card tests and to find the prevalence of co-infection with hepatitis B and hepatitis C viruses from January 2019 to June 2019.Methods: Blood samples were received from patients irrespective of ag

APA, Harvard, Vancouver, ISO, and other styles

50

OHBA, K., M. MIZOKAMI, T. KATO, et al. "Seroprevalence of hepatitis B virus, hepatitis C virus and GB virus-C infections in Siberia." Epidemiology and Infection 122, no. 1 (1999): 139–44. http://dx.doi.org/10.1017/s0950268898001940.

Full text

Abstract:

We studied the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and GB virus-C (GBV-C) infections in 348 Siberian natives who lived in the Kamchatka Peninsula of Russia. Of 348 samples studied, the seroprevalence of HBsAg and anti-HBs were 11·8% (41 of 348 samples) and 35·9% (125 of 348 samples), respectively. The prevalence of HCV infection was 1·4% (5 of 348 samples), and that of GBV-C RNA, using RT–PCR methods, was 7·5% (26 of 348 samples). In Siberia, the prevalences of HBV and GBV-C infections were about tenfold higher than those in Japan. The prevalence of HBsAg in subj

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!